Patient Care Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Patient Care Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Clinical Data
Recent developments announced by Clinical Data
January 14th, 2007
Recent developments announced by Clinical Data. This trend article is an immediate alert from NewsRx to identify the most recent news developments at Clinical Data. Report 1: Clinical Data Inc. (CLDA) announced that it has signed an exclusive worldwide license to an extensive portfolio of patents related to a variation in the Fc gamma receptor IIIA gene. Clinical Data's intent is to develop a therapeutic diagnostic for response to rituximab (Rituxan, Genentech/Biogen-Idec and Mabthera, Hoffmann-La Roche) in the treatment of non-Hodgkin lymphoma (NHL). Rituximab is approved for use in the treatment of NHL and rheumatoid arthritis...
Source: Patient Care Law Weekly (2007-01-14)
|
